Atropine for Children and Adolescent Myopia Progression Study
Status:
Unknown status
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
Investigators are going to conduct a randomized controlled trial that myopic children are
randomly allocated into two groups: combined use of 1% atropine and 0.01% atropine
(experimental group) and 0.01% atropine (control group) in order to explore a better way to
control myopia progression and eliminate adverse effects at the same time, provide reliably
evidence for clinical guideline of atropine use in children, and investigate the mechanism of
atropine on eyes.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Eye Disease Prevention and Treatment Center
Collaborator:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine